XML 54 R37.htm IDEA: XBRL DOCUMENT v3.25.4
Cash, Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2025
Cash, Cash Equivalents and Marketable Securities [Abstract]  
Schedule of Amortized Cost, Gross Unrealized Gains and Losses and Fair Value of Our Cash, Cash Equivalents and Marketable Securities Considered as Available for Sale by Type of Securities
The following table summarizes the amortized cost, gross unrealized gains and losses and the fair value of our cash, cash equivalents and marketable securities, all of which are considered available for sale, by type of securities (in millions):
Types of securities as of December 31, 2025Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Fair
Value
Money market funds$155 $— $— $155 
U.S. treasury securities359 — — 359 
Corporate securities and commercial paper487 — — 487 
Certificate of deposit— — 
Total cash, cash equivalents and marketable securities$1,010 $— $— $1,010 
Types of securities as of December 31, 2024Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Fair
Value
Money market funds$120 $— $— $120 
U.S. treasury securities251 — — 251 
Corporate securities and commercial paper592 — — 592 
U.S. government agency securities— — 
Certificate of deposit24 — — 24 
Total cash, cash equivalents and marketable securities$992 $— $— $992 
Schedule of Fair Values of Our Cash, Cash Equivalents and Marketable Securities by Location in Consolidated Balance Sheets and Contractual Maturity
The following table summarizes the fair values of our cash, cash equivalents and marketable securities by location in the Consolidated Balance Sheets and contractual maturity (in millions):
Contractual
Maturity
As of December 31,
Location in Consolidated Balance Sheets20252024
Cash and cash equivalents$222 $150 
Marketable securitiesWithin one year759 828 
Long-term marketable securitiesBetween one and three years29 14 
Total cash, cash equivalents and marketable securities $1,010 $992 
Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash within the Consolidated Balance Sheets to the total shown in the Consolidated Statements of Cash Flows (in millions):
As of December 31,
20252024
Cash and cash equivalents$222 $150 
Restricted cash (included in Other noncurrent assets)
Total cash, cash equivalents and restricted cash$225 $153